Mobile-Based Contingency Management to Promote Daily Self-monitoring in Primary Care Patients
ProMPT
Using Mobile-based Contingency Management to Promote Daily Self-monitoring of Pain Severity and Prescription Opioid Use in a Primary Care Sample of Chronic Pain Patients
2 other identifiers
interventional
81
1 country
1
Brief Summary
This project examines the efficacy and feasibility of contingency management (CM), delivered using a novel, fully automated CM app (DynamiCare Rewards), to promote daily self-monitoring of pain symptom severity and related variables (e.g., mood, sleep), as well as Rx opioid, alcohol, marijuana, cannabidiol (CBD), and Rx benzodiazepine use in a sample of chronic pain patients. The project will conduct a 2-arm randomized clinical trial (RCT) comparing those receiving reinforcement escalating with continuous performance of the target behavior (CM group) vs those asked to complete the survey but will not be incentivized (C group).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2019
CompletedFirst Posted
Study publicly available on registry
May 24, 2019
CompletedStudy Start
First participant enrolled
January 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2021
CompletedResults Posted
Study results publicly available
December 7, 2022
CompletedDecember 7, 2022
November 1, 2022
1.2 years
May 22, 2019
October 3, 2022
November 11, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Number of Daily Self-monitoring Surveys Completed
Number of days daily surveys completed
28-day daily survey period
Longest Period of Sustained Adherence to Daily Survey Completion
Largest number of consecutive days wherein daily surveys were completed
28-day daily survey period
Secondary Outcomes (2)
Daily Survey Completion Time
28-day daily survey period
CM App Acceptability
28-day follow-up
Other Outcomes (5)
Agreement Between Daily Survey and 28-day Follow-up Reports of Alcohol Use
28-day daily survey period to 28-day follow-up
Agreement Between Daily Survey and 28-day Follow-up Reports of Rx Opioid Use
28-day daily survey period to 28-day follow-up
Agreement Between Daily Survey and 28-day Follow-up Reports of Rx Benzodiazepine Use
28-day daily survey period to 28-day follow-up
- +2 more other outcomes
Study Arms (2)
Daily Self-Monitoring Surveys
OTHERAsked to complete daily self-monitoring surveys.
Daily Self-Monitoring Surveys + Contingency Management
EXPERIMENTALAsked to complete daily self-monitoring surveys, with opportunity for monetary rewards.
Interventions
Asked to complete a brief (5-minute) survey with questions related to pain experience and related measures every day for 28 days using the DynamiCare smartphone app, with the opportunity for monetary rewards for completing daily surveys.
Asked to complete a brief (5-minute) survey with questions related to pain experience and related measures every day for 28 days using the DynamiCare smartphone app.
Eligibility Criteria
You may qualify if:
- at least 18 years of age;
- own a study-compatible smartphone (iPhone or Android device);
- report non-cancer related chronic pain (consistent daily pain) for 3 months or greater;
- able to provide informed consent for study participation;
- used prescription opioids in the past 30 days; and
- having ever been prescribed 1 or more opioid medication(s) for pain management.
You may not qualify if:
- currently pregnant;
- presenting with language barriers, cognitive impairment, or serious medical or psychiatric illness that in the opinion of the Investigator would preclude them from providing informed consent or participating in the study; and
- visual impairment or motor impairment that would interfere with use of a smartphone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Kathryn Polak, PhD
- Organization
- Virginia Commonwealth University
Study Officials
- PRINCIPAL INVESTIGATOR
Dace Svikis, PhD
Virginia Commonwealth University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2019
First Posted
May 24, 2019
Study Start
January 24, 2020
Primary Completion
April 14, 2021
Study Completion
April 14, 2021
Last Updated
December 7, 2022
Results First Posted
December 7, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share